Kidney Research and Clinical Practice

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study

Chang-Yun Yoon, Misol Lee, Seung Up Kim, Hyunsun Lim, Tae Ik Chang, Youn Kyung Kee, Seung Gyu Han, In Mee Han, Young Eun Kwon, Kyoung Sook Park, Mi Jung Lee, Jung Tak Park, Seung Hyeok Han, Sang Hoon Ahn, Shin-Wook Kang, Tae-Hyun Yoo

Kidney Res Clin Pract. 2017;36(1):48-57. Published online March 31, 2017
DOI: https://doi.org/10.23876/j.krcp.2017.36.1.48

Study of Non-alcoholic fatty liver disease among chronic kidney disease patients by Controlled attenuation parameter

Mohamed Mahrous Salem, Sahar Mahmoud Shawky, Maha Abd Elmoneim Behairy, Ahmed Fouad Helmy

QJM: An International Journal of Medicine. 2021;114(Supplement_1):

Link1

Link2

Applicability and Results of Liver Stiffness Measurement and Controlled Attenuation Parameter Using XL Probe for Metabolic-Associated Fatty Liver Disease in Candidates to Bariatric Surgery. A Single-Center Observational Study

Tao Wan, Nastassja Köhn, Dino Kröll, Annalisa Berzigotti

Obesity Surgery. 2020;31(2):702-711

Link1

Link2 Link3

Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study

Kidney Research and Clinical Practice. 2017;36(1):48-57

Link1

Link2

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for Staging Nonalcoholic Fatty Liver Disease

Sebastian Zenovia, Cristina Muzica, Mihaela Dimache

Essentials of Non-Alcoholic Fatty Liver Disease. 2023;107-122

Link1

Association Between Metabolic Associated Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study from NHANES 2017–2018

Yunlei Deng, Qianwen Zhao, Rong Gong

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;Volume 14:1751-1761

Link1 Link2

MO481: Novel Predictors of CKD in Metabolic Fatty Liver Disease Patients: Steatosis Vs Fibrosis. A Prospective Study Using Transient Elastography With Controlled Attenuation Parameter

Luciana Marc, Adelina Mihaescu, Raluca Lupusoru, Flaviu Bob, Lazar Chisavu, Bogdan Timar, Romulus Timar, Adalbert Schiller

Nephrology Dialysis Transplantation. 2022;37(Supplement_3):

Link1

Link2

The correlation between controlled attenuation parameter and metabolic syndrome and its components in middle-aged and elderly nonalcoholic fatty liver disease patients

Yue-Yan Hu, Ning-Ling Dong, Qiu Qu, Xu-Fan Zhao, Hong-Ju Yang

Medicine. 2018;97(43):e12931

Link1

Use of Vibration-Controlled Transient Elastography (VCTE) with Simultaneous Liver Stiffness Measurement (LSM) and Controlled Attenuation Parameter (CAP) in Patients Referred for Suspected Non-Alcoholic Fatty Liver Disease (NAFLD): A Prospective Study

Lara Dakhoul, Oscar W. Cummings, Regina Weber, Raj Vuppalanchi

Gastroenterology. 2017;152(5):S1115-S1116

Link1 Link2

Steatosis assessment by controlled attenuation parameter in patients with compensated advanced chronic liver disease

Ivica Grgurevic, Nermin Salkic, Anita Madir, Gorana Aralica

Liver International. 2020;40(7):1784-1785

Link1 Link2 Link3 Link4

Usefulness of liver test and controlled attenuation parameter in detection of nonalcoholic fatty liver disease in patients with chronic renal failure and coronary heart disease

Ivana Mikolasevic, Lidija Orlic, Luka Zaputovic, Sanjin Racki, Zlatko Cubranic, Kata Anic, Bosiljka Devcic, Davor Stimac

Wiener klinische Wochenschrift. 2015;127(11-12):451-458

Link1

Link2 Link3